Cargando…

The safety of pericardiocentesis in patients under antithrombotic therapy: A single-center experience

OBJECTIVE: This study aimed to analyze the characteristics of patients with pericardial effusion requiring pericardiocentesis and to evaluate the safety of pericardiocentesis without discontinuation of anticoagulant or antiplatelet drugs. METHODS: We performed a retrospective study of patients under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yuansong, Zhang, Chengxiang, Xie, Yuqiao, Sasmita, Bryan Richard, Xiang, Zhenxian, Jiang, Yi, Gong, Ming, Wang, Yaxin, Chen, Siyu, Luo, Suxin, Huang, Bi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532565/ https://www.ncbi.nlm.nih.gov/pubmed/36211575 http://dx.doi.org/10.3389/fcvm.2022.1013979

Ejemplares similares

The prognostic value of admission D-dimer level in patients with cardiogenic shock after acute myocardial infarction
por: Jiang, Yi, et al.
Publicado: (2023)

Associations of Lipoprotein(a) With Coronary Atherosclerotic Burden and All-Cause Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
por: Xue, Yuzhou, et al.
Publicado: (2021)

Pneumopericardium Resulting After Pericardiocentesis
por: Kawanami, Yuka, et al.
Publicado: (2023)

Prognostic Factors and Overall Survival After Pericardiocentesis in Patients With Cancer and Thrombocytopenia
por: Wilson, Nathaniel R., et al.
Publicado: (2021)

Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis
por: Ahmed, Talha, et al.
Publicado: (2022)

Hydropneumopericardium after pericardiocentesis in a transplant patient
por: Planchat, Arnaud, et al.
Publicado: (2023)

Pneumopericardium After the Removal of a Pericardiocentesis Drain
por: Tanabe, Junya, et al.
Publicado: (2023)

Blood Urea Nitrogen for Short-Term Prognosis in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction
por: Zhu, Yuansong, et al.
Publicado: (2022)

Clinical characteristics and risk factors of in-hospital mortality among patients undergoing percutaneous pericardiocentesis
por: Wybraniec, Maciej T., et al.
Publicado: (2023)

Case report: Successful treatment of malignant pericardial effusion with pericardiocentesis, concurrent anti-inflammatory therapy and cancer therapy
por: Lee, Nuri, et al.
Publicado: (2023)

Ivabradine in patients with acute ST-elevation myocardial infarction: a meta-analysis of randomized controlled trials
por: Sasmita, Bryan Richard, et al.
Publicado: (2023)

Novel dry pericardiocentesis: Transvenous puncture of the right ventricle with the back end of a 0.014-inch PTCA guidewire and a 1.8 Fr microcatheter
por: Qin, Hua-Di, et al.
Publicado: (2022)

Antithrombotic therapy in peripheral arterial disease
por: Espinola-Klein, Christine, et al.
Publicado: (2022)

Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Liang, Bo, et al.
Publicado: (2022)

Antithrombotic Therapy in Transcatheter Aortic Valve Replacement
por: Valvo, Roberto, et al.
Publicado: (2019)

Virtual reality as a therapy adjunct during emergency pericardiocentesis
por: Mitchell, Andrew R J, et al.
Publicado: (2020)

Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial Fibrillation
por: Wu, Yangxun, et al.
Publicado: (2022)

Antithrombotic Treatment in Lower Extremity Peripheral Arterial Disease
por: Gottsäter, Anders
Publicado: (2021)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

Antithrombotic Treatment After Surgical and Transcatheter Heart Valve Repair and Replacement
por: Verstraete, Andreas, et al.
Publicado: (2021)

Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis
por: Sim, Martha M. S., et al.
Publicado: (2023)

A rare complication of catherer insertion pericardiocentesis
por: Davakis, Spyridon, et al.
Publicado: (2017)

The prognostic value of advanced lung cancer inflammation index (ALI) in elderly patients with heart failure
por: Yuan, Xiao, et al.
Publicado: (2022)

Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions
por: Galli, Mattia, et al.
Publicado: (2023)

Editorial: Antithrombotic Treatment in Transcatheter Structural Cardiac Interventions and After Cardiac Device Implantation
por: Siller-Matula, Jolanta M., et al.
Publicado: (2020)

Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Rotational Thromboelastometry in High-Risk Patients on Dual Antithrombotic Therapy After Percutaneous Coronary Intervention
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Safety and efficacy of dual versus triple antithrombotic therapy (DAT vs TAT) in patients with atrial fibrillation following a PCI: a systematic review and network meta-analysis
por: Altoukhi, Renad M, et al.
Publicado: (2020)

Safety Pericardiocentesis with Fluoroscopy Following Cardiac Surgery
por: Alp, Ibrahim, et al.
Publicado: (2019)

Coronary and mortality risk of novel oral antithrombotic agents: a meta-analysis of large randomised trials
por: Mak, Koon-Hou
Publicado: (2012)

Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome?
por: Laborante, Renzo, et al.
Publicado: (2022)

Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions—PFO/ASD/LAA Occluder and Interatrial Shunt Devices
por: Olasinska-Wisniewska, Anna, et al.
Publicado: (2019)

Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention
por: Liu, Hangkuan, et al.
Publicado: (2021)

The Characteristics, Long-Term Outcomes, Risk Factors, and Antithrombotic Therapy in Chinese Patients With Atrial Fibrillation and Bioprosthetic Valves
por: Ren, Jiameng, et al.
Publicado: (2021)

Stroke prevention during and after transcatheter aortic valve implantation: From cerebral protection devices to antithrombotic management
por: Jimenez Diaz, Victor Alfonso, et al.
Publicado: (2022)

Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
por: Cameron, Chris, et al.
Publicado: (2014)

Temporal Trends of Antithrombotic Therapy in Patients With Acute Myocardial Infarction and Atrial Fibrillation: Insight From the KAMIR-NIH Registry
por: Lee, Oh-Hyun, et al.
Publicado: (2021)

Antithrombotic regimens in females with symptomatic lower extremity peripheral arterial disease: protocol for a systematic review and meta-analysis
por: Strauss, Shira A, et al.
Publicado: (2021)

Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
por: Zhao, Shujuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t0puaukgtt6l1e9j09cb1380k0